Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

Statistical Learning Theory

1999 • 27,709 citations

Inflammation and cancer

2002 • 14,174 citations

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

2002 • 6,428 citations

Basic principles of ROC analysis

1978 • 5,844 citations

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

2002 • 3,769 citations

Use of proteomic patterns in serum to identify ovarian cancer

2002 • 3,227 citations

Cancer Statistics, 2002

2002 • 2,954 citations

The CA 125 tumour-associated antigen: a review of the literature

1989 • 931 citations

Proteomics and Bioinformatics Approaches for Identification of Serum Biomarkers to Detect Breast Cancer

2002 • 898 citations

Serum Proteomic Patterns for Detection of Prostate Cancer

2002 • 758 citations

Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool

2004 • 644 citations

The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease*

2001 • 636 citations

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

2004 • 632 citations

New desorption strategies for the mass spectrometric analysis of macromolecules

1993 • 632 citations

Screening for ovarian cancer: a pilot randomised controlled trial

1999 • 563 citations

Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients

2002 • 438 citations

Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine

2001 • 419 citations

Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential Problems

2004 • 403 citations

CA 125: The past and the Future

1998 • 396 citations

The Efficacy of Transvaginal Sonographic Screening in Asymptomatic Women at Risk for Ovarian Cancer

2000 • 351 citations

Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology

2001 • 289 citations

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis

2003 • 276 citations

Human Tissue Kallikreins: A Family of New Cancer Biomarkers

2002 • 242 citations

Proteomic Approaches to Tumor Marker Discovery

2002 • 222 citations

Organ-Specific Molecular Classification of Primary Lung, Colon, and Ovarian Adenocarcinomas Using Gene Expression Profiles

2001 • 209 citations

Protein biochips for differential profiling

2001 • 201 citations

Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization–International Federation of Clinical Chemistry First International Reference Materials

1998 • 159 citations

Parallel overexpression of seven kallikrein genes in ovarian cancer.

2003 • 153 citations

Apolipoprotein B and AI distributions in the United States, 1988-1991: results of the National Health and Nutrition Examination Survey III (NHANES III).

1997 • 152 citations

Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal Markers

2001 • 144 citations

The past and the future

1965 • 142 citations

Diagnostic Potential of Serum Proteomic Patterns in Prostate Cancer

2003 • 138 citations

Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III)

1997 • 132 citations

Biochemical Basis for Depressed Serum Retinol Levels in Transthyretin-deficient Mice

2001 • 123 citations

Application of laser capture microdissection and proteomics in colon cancer

2001 • 122 citations

OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma

2001 • 107 citations

Combinations of Multiple Serum Markers Are Superior to Individual Assays for Discriminating Malignant from Benign Pelvic Masses

1995 • 107 citations

cDNA and deduced amino acid sequence of human PK‐120, a plasma kallikrein‐sensitive glycoprotein

1995 • 80 citations

Combination of Multiple Serum Markers Using an Artificial Neural Network to Improve Specificity in Discriminating Malignant from Benign Pelvic Masses

1999 • 79 citations

Plasma Prealbumin in Women with Epithelial Ovarian Carcinoma

1994 • 48 citations

Screening for ovarian cancer

2002 • 47 citations

Purification and characterization of a novel substrate for plasma kallikrein (PK-120) in human plasma

1994 • 45 citations

Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer.

2003 • 45 citations

Decreased Expression of Retinol-Binding Proteins is Associated with Malignant Transformation of the Ovarian Surface Epithelium

2002 • 43 citations

Kallikreins, steroid hormones and ovarian cancer: is there a link?

2002 • 36 citations

Bilateral Oophorectomy in Asymptomatic Women over 50 Years Old Selected by Ovarian Cancer Screening

1999 • 33 citations

Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease

1992 • 28 citations

Applying Classification Separability Analysis to Microarray Data

2002 • 21 citations

Methods of microarray data analysis : papers from CAMDA

2002 • 18 citations

Fishing Expedition - a Supervised Approach to Extract Patterns from a Compendium of Expression Profiles

2005 • 4 citations